Hazard screening of photo-transformation products from pharmaceuticals: Application to selective β1-blockers atenolol and metoprolol

Backhaus, 2000, Predictability of the toxicity of a multiple mixture of dissimilarly acting chemicals to Vibrio fischeri, Environ. Toxicol. Chem., 19, 2348, 10.1002/etc.5620190927 Belfroid, 1998, Relative risks of transformation products of pesticides for aquatic ecosystems, Sci. Total Environ., 222, 167, 10.1016/S0048-9697(98)00298-8 Benigni, 2005, Simple and alpha,beta-unsaturated aldehydes: correct prediction of genotoxic activity through structure-activity relationship models, Environ. Mol. Mutagen., 46, 268, 10.1002/em.20158 Brambilla, 2006, Genotoxicity and carcinogenicity studies of antihypertensive agents, Mutat. Res., 612, 115, 10.1016/j.mrrev.2005.12.002 Bryce, 2010, High content flow cytometric micronucleus scoring method is applicable to attachment cell lines, Environ. Mol. Mutagen., 51, 260 Četojević-Simin, 2013, Toxicity assessment of metoprolol and its photodegradation mixtures obtained by using different type of TiO2 catalysts in the mammalian cell lines, Sci. Total Environ., 463–464, 968, 10.1016/j.scitotenv.2013.06.083 Chakravarti, 2012, Optimizing predictive performance of CASE Ultra expert system models using the applicability domains of individual toxicity alerts, J. Chem. Inf. Model., 52, 2609, 10.1021/ci300111r Cleuvers, 2005, Initial risk assessment for three beta-blockers found in the aquatic environment, Chemosphere, 59, 199, 10.1016/j.chemosphere.2004.11.090 Contardo-Jara, 2010, The beta-receptor blocker metoprolol alters detoxification processes in the non-target organism Dreissena polymorpha, Environ. Pollut., 158, 2059, 10.1016/j.envpol.2010.03.012 EPA, 2012, Chapter 5: estimating physical/chemical and environmental fate properties with EPI Suite™ Escher, 2011, Recent advances in environmental risk assessment of transformation products, Environ. Sci. Technol., 45, 3835, 10.1021/es1030799 Escher, 2006, Comparative ecotoxicological hazard assessment of beta-blockers and their human metabolites using a mode-of-action-based test battery and a QSAR approach, Environ. Sci. Technol., 40, 7402, 10.1021/es052572v European Commission, 2003 Hapeshi, 2010, Drugs degrading photocatalytically: kinetics and mechanisms of ofloxacin and atenolol removal on titania suspensions, Water Res., 44, 1737, 10.1016/j.watres.2009.11.044 ICH, 2014, Assessment and control of DNA reactive (mutagenic) impurities in pharmaceuticals to limit potential carcinogenic risk M7 ISO, 2000 Ji, 2012, Nitrate-induced photodegradation of atenolol in aqueous solution: kinetics, toxicity and degradation pathways, Chemosphere, 88, 644, 10.1016/j.chemosphere.2012.03.050 Kazius, 2005, Derivation and validation of toxicophores for mutagenicity prediction, J. Med. Chem., 48, 312, 10.1021/jm040835a Klopman, 2003, Multiple computer-automated structure evaluation study of aquatic toxicity. III. Vibrio fischeri, Environ. Toxicol. Chem., 22, 466, 10.1002/etc.5620220302 Küster, 2010, Environmental risk assessment of human pharmaceuticals in the European Union: a case study with the β-blocker atenolol, Integr. Environ. Assess. Manag., 514 La Farré, 2008, Fate and toxicity of emerging pollutants, their metabolites and transformation products in the aquatic environment. TrAC, Trends Anal. Chem., 27, 991, 10.1016/j.trac.2008.09.010 Libralato, 2008, Evaporation and air-stripping to assess and reduce ethanolamines toxicity in oily wastewater, J. Hazard. Mater., 153, 928, 10.1016/j.jhazmat.2007.09.042 Liu, 2009, Photo-induced environmental depletion processes of beta-blockers in river waters, Photochem. Photobiol. Sci., 8, 768, 10.1039/b817890a Mahmoud, 2014, Identification of phototransformation products of thalidomide and mixture toxicity assessment: an experimental and quantitative structural activity relationships (QSAR) approach, Water Res., 49, 11, 10.1016/j.watres.2013.11.014 Martelli, 1994, Low clastogenic activity in vivo of the N-nitroso derivatives of 5 beta-adrenergic-blocking drugs proved to be potent genotoxins in vitro, Toxicol. Lett., 73, 185, 10.1016/0378-4274(94)90057-4 Maszkowska, 2014, Beta-blockers in the environment: part I. Mobility and hydrolysis study, Sci. Total Environ., 493, 1112, 10.1016/j.scitotenv.2014.06.023 Menz, 2013, Toxicity testing with luminescent bacteria—characterization of an automated method for the combined assessment of acute and chronic effects, Chemosphere, 93, 990, 10.1016/j.chemosphere.2013.05.067 Okine, 1983, Studies on the possible mutagenicity of beta-adrenergic blocker drugs, Toxicol. Lett., 16, 167, 10.1016/0378-4274(83)90175-3 Piram, 2008, Photolysis of beta-blockers in environmental waters, Chemosphere, 73, 1265, 10.1016/j.chemosphere.2008.07.018 Radjenović, 2008, Identification and structural characterization of biodegradation products of atenolol and glibenclamide by liquid chromatography coupled to hybrid quadrupole time-of-flight and quadrupole ion trap mass spectrometry, J. Chromatogr. A, 1210, 142, 10.1016/j.chroma.2008.09.060 Rastogi, 2014, Qualitative environmental risk assessment of photolytic transformation products of iodinated X-ray contrast agent diatrizoic acid, Sci. Total Environ., 482–483, 378, 10.1016/j.scitotenv.2014.02.139 Rastogi, 2014, Designing green derivatives of β-blocker metoprolol: a tiered approach for green and sustainable pharmacy and chemistry, Chemosphere, 111, 493, 10.1016/j.chemosphere.2014.03.119 Rastogi, 2015, A sustainable chemistry solution to the presence of pharmaceuticals and chemicals in the aquatic environment – the example of re-designing β-blocker atenolol, RSC Adv., 5, 27, 10.1039/C4RA10294K Richard, 2014, Toxicity of the micropollutants bisphenol A, ciprofloxacin, metoprolol and sulfamethoxazole in water samples before and after the oxidative treatment, Int. J. Hyg. Environ. Health, 217, 506, 10.1016/j.ijheh.2013.09.007 Richardson, 2011, Water analysis: emerging contaminants and current issues, Anal. Chem., 83, 4614, 10.1021/ac200915r Robbiano, 1991, Formation of the N-nitroso derivatives of six beta-adrenergic-blocking agents and their genotoxic effects in rat and human hepatocytes, Cancer Res., 51, 2273 Roberts, 2000, LeadScope: software for exploring large sets of screening data, J. Chem. Inf. Model., 40, 1302 Rocco, 2012, Genotoxic effects in fish induced by pharmacological agents present in the sewage of some Italian water-treatment plants, Environ. Toxicol., 27, 18, 10.1002/tox.20607 Romero, 2011, Photocatalytic treatment of metoprolol and propranolol, Catal. Today, 161, 115, 10.1016/j.cattod.2010.09.026 Saiakhov, 2013, Effectiveness of CASE Ultra expert system in evaluating adverse effects of drugs, Mol. Inf., 32, 87, 10.1002/minf.201200081 Scherrer, 2010, Multi-pH QSAR: a method to differentiate the activity of neutral and ionized species and obtain true correlations when both species are involved, Mol. Inf., 29, 687, 10.1002/minf.201000093 Šojić, 2012, Degradation of thiamethoxam and metoprolol by UV, O3 and UV/O3 hybrid processes: kinetics, degradation intermediates and toxicity, J. Hydrol., 472–473, 314, 10.1016/j.jhydrol.2012.09.038 Télez, 2000, In vitro and in vivo evaluation of the antihypertensive drug atenolol in cultured human lymphocytes: effects of long-term therapy, Mutagenesis, 15, 195, 10.1093/mutage/15.3.195 Toolaram, 2014, Environmental risk assessment of anti-cancer drugs and their transformation products: a focus on their genotoxicity characterization-state of knowledge and short comings, Mutat. Res. Rev. Mutat. Res., 760, 18, 10.1016/j.mrrev.2014.02.001 van den Brandhof, 2010, Fish embryo toxicity of carbamazepine, diclofenac and metoprolol, Ecotoxicol. Environ. Saf., 73, 1862, 10.1016/j.ecoenv.2010.08.031 Verhaar, 1992, Classifying environmental pollutants, Chemosphere, 25, 471, 10.1016/0045-6535(92)90280-5 Verlicchi, 2012, Occurrence of pharmaceutical compounds in urban wastewater: removal, mass load and environmental risk after a secondary treatment—a review, Sci. Total Environ., 429, 123, 10.1016/j.scitotenv.2012.04.028